Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 6Breast 3Head & Neck 2Gastrointestinal 2CNS 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Lymphoid 1

Conditions

Glioblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 171Bevacizumab 106Radiotherapy 87Radiation 38Cyclophosphamide 38Etoposide 34Carboplatin 34Magnetic Resonance Spectroscopy 32Irinotecan 32Radiosurgery 27Vincristine 25pembrolizumab 24Everolimus 23Cisplatin 23Nivolumab 22Radiotherapy, Intensity-Modulated 19Isotretinoin 19Filgrastim 19Erlotinib Hydrochloride 19Topotecan 18Lomustine 17Vorinostat 16Doxorubicin 16Granulocyte Colony-Stimulating Factor 15sargramostim 14antineoplaston A10 13Radiotherapy, Conformal 13antineoplaston AS 2-1 12Granulocyte-Macrophage Colony-Stimulating Factor 12dinutuximab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Positron Emission Tomography Computed Tomography × CNS × Clear all
NCT01604512 2025-04-08

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Memorial Sloan Kettering Cancer Center

Phase NA Completed
148 enrolled 9 charts
CNS

Brain Neoplasms

NCT02410577 2019-03-19

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Memorial Sloan Kettering Cancer Center

Phase NA Completed
2 enrolled 5 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡